Identifying injection drug users at risk of nonfatal overdose.
about
Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the LiteratureEstimated drug overdose deaths averted by North America's first medically-supervised safer injection facilityAlcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsAddressing the overdose epidemic requires timely access to data to guide interventions.Primary Care Patient Experience with Naloxone Prescription.Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.Circumstances surrounding non-fatal opioid overdoses attended by ambulance servicesAssociations among pain, non-medical prescription opioid use, and drug overdose history.Risk factors for nonfatal overdose at Seattle-area syringe exchanges.Characteristics of drug users who witness many overdoses: implications for overdose prevention.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.Drug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting.The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.Correlates of overdose risk perception among illicit opioid users.Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or painIncidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug usersNon-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs.Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities.Pitfalls of intranasal naloxone.A procedure that differentiates unintentional from intentional overdose in opioid abusersEMS runs for suspected opioid overdose: implications for surveillance and prevention.The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting.Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.Gender and comorbidity among individuals with opioid use disorders in the NESARC study.Circumstances and witness characteristics associated with overdose fatality.Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting.Identifying Patients for Overdose Prevention With ICD-9 Classification in the Emergency Department, Massachusetts, 2013-2014.Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.Opioid overdose and the power of old myths: what we thought we knew, what we do know and why it matters.Randomized controlled trial of a computerized opioid overdose education intervention.A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder.Recent Overdose Experiences in a Community Sample of Military Veterans Who Use Opioids.Qualitative evaluation of suicide and overdose risk assessment procedures among veterans in substance use disorder treatment clinics.Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs.Overdose and adverse drug event experiences among adult patients in the emergency department.An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
P2860
Q26785445-8299DEBC-C446-4BC6-968D-1BB9150AF01EQ28473764-8D193902-8EC6-4AC7-A79C-4E2F08A3C8A4Q30244921-51C93DE0-A01C-4B84-BCB6-32A2EC66C562Q30994233-559A660F-326F-43C5-818D-5FC06A30CF36Q33572144-2EF63790-1A66-45AD-95E7-45640EB06F71Q33691974-626B6196-CF91-4556-9F51-725CC96D8CA0Q33697978-538E4F40-2CEE-4F7B-B58A-4A25FA099DB9Q33724605-13E1F937-932B-490E-8C89-9900920EE754Q34588009-1A29885F-274F-41E4-AAE3-73C1D997B04DQ35589591-CA0D2D3A-7D51-4A0A-AC3B-A71324A96287Q35751870-CCEAF14D-C526-435D-AB01-1F6E3D4A717CQ35855231-9F059DEF-6396-4E79-A18F-95C8C96E0AE1Q35873412-1F9F3BAA-882E-4C16-9F17-4BA6770CCA1CQ35875932-582779AF-82ED-485A-ADE7-62839D9FA13BQ36248958-2B83BED4-B7BF-4FFF-BD3D-2C0BDBBC28CDQ36525439-C8ABED1A-69E1-4435-BECC-E7D3997E14DEQ36574620-AA6E823B-51C6-4E49-9B53-E5393034248EQ36733932-C5EB45F9-95DE-44DC-9F57-E98B42340CC6Q36803528-B832C69F-DDC6-4CCA-8211-53A1C2ACDAC3Q36853512-5E0A12CB-9A43-496C-ADEA-C77FE905F411Q36891449-51B83579-DD75-4A5D-B4C6-B50EA356FBDDQ36894301-06DB2235-C3B9-4A19-940E-E7EA733A2296Q36929678-3DF8CC1C-A03E-4C02-A129-576437038C76Q37164972-DA5CBE41-D071-4DB4-930C-E82B99685BFDQ37225942-E1671B22-6999-40BB-92E2-A4167E2C9081Q37255520-7AF5ACA7-FBC4-436F-B3D9-5D8FCDFD3DA8Q37390705-8DEC8EAA-F41B-4536-A5EA-7087D059995DQ38661227-00C062EB-22FA-42DA-9F6C-3E5FF5708E70Q38817326-5FE25D10-9A52-4E44-93B0-30A83C27771EQ40364254-7EACEFCD-9303-45F6-9520-045FCAB40325Q44137641-281EE9D1-3D20-495B-9000-688455FAEA74Q44343656-414C3435-550A-4D65-9C47-E9F9B19AADFEQ44344528-69EDDE69-3E5D-4643-901B-EDE34B873AB9Q44349064-0EB7EEE1-A508-4A48-A3DE-BE9DE5CB57F4Q45326281-F7A4E2A7-5A32-4397-9FB6-BB904AE14800Q45329989-83AE916E-411F-4E3A-A9FD-E14192CB7F72Q47214991-9B8870A1-B6B7-47A1-BE43-3D36138F2D6AQ47563410-FDC1CE47-C07A-4F9C-A85D-14E45FE784F1Q47568251-CBDCC8DD-65B8-4DA6-BA72-288C53FA959CQ47580649-A2B6318D-61D8-40D8-B7C0-F19990FD2153
P2860
Identifying injection drug users at risk of nonfatal overdose.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identifying injection drug users at risk of nonfatal overdose.
@en
Identifying injection drug users at risk of nonfatal overdose.
@nl
type
label
Identifying injection drug users at risk of nonfatal overdose.
@en
Identifying injection drug users at risk of nonfatal overdose.
@nl
prefLabel
Identifying injection drug users at risk of nonfatal overdose.
@en
Identifying injection drug users at risk of nonfatal overdose.
@nl
P2093
P2860
P50
P1476
Identifying injection drug users at risk of nonfatal overdose.
@en
P2093
Angela Bucciarelli
Melissa Tracy
Sandro Galea
P2860
P304
P356
10.1111/J.1553-2712.2007.TB01846.X
P577
2007-06-06T00:00:00Z